Chromosome 21 abnormality tells oncologists to treat pediatric ALL more aggressively
A recent study by members of the Children’s Oncology Group reports results of a large trial showing that children whose leukaemia cells have amplification of a portion of chromosome 21 may require more aggressive treatment for Acute Lymphoblastic Leukaemia (ALL) than children without this gene amplification. ‘This helps identify patients who need more therapy than […]
